Comprehensive Financial Consultants Institutional’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,150
Closed -$219K 155
2023
Q3
$219K Sell
4,150
-51
-1% -$2.67K 0.12% 145
2023
Q2
$221K Sell
4,201
-197
-4% -$10.3K 0.12% 155
2023
Q1
$220K Sell
4,398
-36
-0.8% -$1.7K 0.12% 151
2022
Q4
$207K Buy
+4,434
New +$192K 0.13% 156
2022
Q1
Sell
-497
Closed -$22K 188
2021
Q4
$22K Buy
+497
New +$20.9K 0.01% 296

Other funds holding BSX

Comprehensive Financial Consultants Institutional's BSX Position: Q4 2023 in Review

Comprehensive Financial Consultants Institutional sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 4,150 shares — an estimated $219K sold.

Comprehensive Financial Consultants Institutional first reported a position in BSX in Q4 2021 and held it in 5 quarters. The position peaked at $221K in Q2 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Comprehensive Financial Consultants Institutional reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
  • Comprehensive Financial Consultants Institutional sold 4,150 Boston Scientific shares in Q4 2023, an estimated $219K.
  • Comprehensive Financial Consultants Institutional first reported a position in Boston Scientific in Q4 2021 and held it in 5 quarters.
  • Comprehensive Financial Consultants Institutional's Boston Scientific position peaked at $221K in Q2 2023.
  • 1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Comprehensive Financial Consultants Institutional's 13F filing for Q4 2023, filed 24 Jan 2024.